InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (5 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
5
T+90 hit rate
25%
T+90 mean return
-22.6%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Hecht Beth, Executive. Insider active across 3 companies, notably Xeris Biopharma Holdings, Inc.. In total, 16 filings have been recorded. Breakdown: 0 buy · 5 sells. Total volume traded: €581k. Activity tracked since 3 January 2022. The latest transaction was filed on 1 May 2026 (Cession). Regulator: SEC (Form 4). All data is free.
Declarations16 total
16,667 shares@ US$6.22820.0071% mcap15.2% of flowCommon StockSEC:0001652410-26-000010:0
16,667 shares@ US$5.991412.9% of flowCommon StockSEC:0001652410-26-000008:0
16,667 shares@ US$7.0067Common StockSEC:0001652410-25-000005:0
16,667 shares@ US$7.397613.7% of flowCommon StockSEC:0001652410-25-000003:0
40,000 shares@ US$5.431140.2% of flowCommon StockSEC:0001867096-25-000047:0
45,909 shares@ US$3.5631.7% of flowCommon StockSEC:0001867096-25-000025:0
32,039 shares@ US$3.6122.7% of flowCommon StockSEC:0001867096-25-000011:0
14,037 shares@ US$2.115.4% of flowCommon StockSEC:0001867096-24-000170:0
750,000 shares0Common StockSEC:0001867096-24-000015:0
15,853 shares0Ordinary SharesSEC:0001209191-23-037406:0
350,000 shares0Common StockSEC:0001867096-23-000020:0
36,798 shares0Ordinary SharesSEC:0001209191-22-039311:0
7,642 shares0Ordinary SharesSEC:0001209191-22-020618:0
225,000 shares0Common StockSEC:0001867096-22-000009:0
26,366 sharesCommon StockSEC:0000899243-21-039248:0
26,366 sharesCommon StockSEC:0000899243-21-039317:0
16 of 16 declarations
About Hecht Beth
Beth Hecht is an Executive at Xeris Biopharma Holdings, Inc., Xeris Pharmaceuticals Inc, and Iterum Therapeutics plc. She plays a key role in the strategic direction of these companies, bringing her expertise in product development and research. Her commitment is essential for achieving growth objectives.
